Clinical Trial Update: Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating addition of pembrolizumab to standard chemotherapy for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Carcinoma of the Ovary Hypercalcemic Type

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Small Cell Ovarian Carcinoma | Phase 2 | Status: RECRUITING